Press Releases - 2020-01-15

Date	Title	Company
15-Jan-2020	Pre-close trading update confirms 2019 trading in-line with expectations	Vectura
15-Jan-2020	Independent Panthera Biopartners appoints Stuart Young as CEO as the company further strengthens its team.	Panthera Biopartners
15-Jan-2020	Alliance Healthcare Launches Online Portal	Alliance Healthcare
15-Jan-2020	OGT unveils reliable somatic CNV detection for CLL with new NGS panel	Oxford Gene Technology
15-Jan-2020	Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform for Next Generation Antibody Discovery	Carterra, Inc
15-Jan-2020	Almirall to participate in J.P. Morgan Healthcare Conference in San Francisco	Almirall
15-Jan-2020	Dovato (dolutegravir/lamivudine), the once-daily, single-pill, 2-drug regimen for the treatment of HIV-1 infection, granted marketing approval by Japan Ministry of Health, Labour and Welfare	ViiV Healthcare
15-Jan-2020	Dovato (dolutegravir/lamivudine), the once-daily, single-pill, 2-drug regimen for the treatment of HIV-1 infection, granted marketing approval by Japan Ministry of Health, Labour and Welfare	ViiV Healthcare
15-Jan-2020	The UK and the NHS are providing the right environment and infrastructure to allow innovative cell and gene therapies to reach patients.	The Cell and Gene Therapy Catapult (CGT Catapult)
15-Jan-2020	OPEN Health expands offering with the launch of a new Learning & Development specialist team	OPEN Health
15-Jan-2020	Sygnature Discovery strengthens DMPK team	Sygnature Discovery
15-Jan-2020	Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector	Windgap Medical, Inc.
15-Jan-2020	Mark Antonacci Joins KJT Group as Executive Vice President of Commercial Operations	KJT Group, Inc.
15-Jan-2020	Astellas Completes Acquisition of Audentes Therapeutics	Astellas Pharma Inc.
15-Jan-2020	Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions	Bloom Science
15-Jan-2020	Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study of Investigational Agent Alvocidib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Following Treatment with Venetoclax and HMA Combination Therapy	Tolero Pharmaceuticals, Inc.
15-Jan-2020	Inovio Welcomes Biotech Leader to its Board of Directors	Inovio Pharmaceuticals, Inc.
15-Jan-2020	NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis	NuMedii, Inc.
15-Jan-2020	Orthobiology Market Innovative Technologies, Current And Future Trends	Wired Release
15-Jan-2020	Bioanalytical Testing services Market Plays A Vital Role In Healthcare Industry	Wired Release